DigiNepal Health ENनेहि

← स्वास्थ्य · औषधि

Paclitaxel

Microtubule Inhibitor

WHO अत्यावश्यक औषधि EML खण्ड: Cytotoxic medicines

यो जानकारी मात्र हो, प्रिस्क्रिप्सन होइन। कुनै पनि औषधि लिनुअघि डाक्टर वा फार्मासिस्टसँग सल्लाह लिनुहोस्। ओभरडोज वा विषाक्तता भए १०२ मा फोन गर्नुहोस्।

ब्रान्ड नाम

Nepal brand names not included: no licence-safe source.

What it is used for

Paclitaxel Injection, USP is indicated as subsequent therapy for the treatment of advanced carcinoma of the ovary. As first-line therapy, Paclitaxel Injection, USP is indicated in combination with cisplatin. Paclitaxel Injection, USP is indicated for the adjuvant treatment of node-positive breast cancer administered sequentially to standard doxorubicin-containing combination chemotherapy.

Common side effects

Pooled Analysis of Adverse Event Experiences from Single-Agent Studies Data in the following table are based on the experience of 812 patients (493 with ovarian carcinoma and 319 with breast carcinoma) enrolled in 10 studies who received single-agent Paclitaxel Injection. TABLE 10. b All patients received premedication.

Do not use if (contraindications)

Paclitaxel is contraindicated in patients who have a history of hypersensitivity reactions to paclitaxel or other drugs formulated in polyoxyl 35 castor oil.

Pregnancy & breastfeeding

Pregnancy (label summary): (See WARNINGS section). Breastfeeding (label summary): Nursing Mothers It is not known whether the drug is excreted in human milk.

ओभरडोज वा विषाक्तता

ओभरडोज वा विषाक्तता शंका भए अहिले नै १०२ मा फोन गर्नुहोस्।

१०२

सामान्य प्रश्न

What is Paclitaxel used for?
Paclitaxel Injection, USP is indicated as subsequent therapy for the treatment of advanced carcinoma of the ovary. As first-line therapy, Paclitaxel Injection, USP is indicated in combination with cisplatin.

What are the side effects of Paclitaxel?
Pooled Analysis of Adverse Event Experiences from Single-Agent Studies Data in the following table are based on the experience of 812 patients (493 with ovarian carcinoma and 319 with breast carcinoma) enrolled in 10 studies who received single-agent Paclitaxel Injection. TABLE 10.

Who should not take Paclitaxel?
Paclitaxel is contraindicated in patients who have a history of hypersensitivity reactions to paclitaxel or other drugs formulated in polyoxyl 35 castor oil.

Does Paclitaxel have a boxed warning?
Paclitaxel should be administered under the supervision of a physician experienced in the use of cancer chemotherapeutic agents. Appropriate management of complications is possible only when adequate diagnostic and treatment facilities are readily available.

Can I take Paclitaxel in pregnancy or while breastfeeding?
Pregnancy (label summary): (See WARNINGS section). Breastfeeding (label summary): Nursing Mothers It is not known whether the drug is excreted in human milk.

What is the dose of Paclitaxel?
Not provided here. Ask a doctor or pharmacist.

Paclitaxel के हो?
Paclitaxel is used for: Paclitaxel Injection, USP is indicated as subsequent therapy for the treatment of advanced carcinoma of the ovary. It belongs to the class: Microtubule Inhibitor. Common side effects include: Pooled Analysis of Adverse Event Experiences from Single-Agent Studies Data in the following table ar…

Paclitaxel का साइड इफेक्ट के हुन्?
Pooled Analysis of Adverse Event Experiences from Single-Agent Studies Data in the following table are based on the experience of 812 patients (493 with ovarian carcinoma and 319 with breast carcinoma) enrolled in 10 studies who received single-agent Paclitaxel Injection. TABLE 10. b All patients received premedicat…

स्रोत: FDA SPL label (openFDA/DailyMed); RxNorm (NLM) · Reference · Reference · Reference

US FDA DailyMed; NLM RxNorm

आपत्काल — फोन102